全球妊娠毒血症診斷市場

到 2030 年，全球妊娠毒血症診斷市場規模將達到 35 億美元

2024 年全球妊娠毒血症診斷市場規模估計為 20 億美元，預計 2030 年將達到 35 億美元，2024 年至 2030 年的複合年成長率為 9.6%。血液檢測是報告中分析的細分市場之一，預計複合年成長率為 11.0%，在分析期結束時達到 22 億美元。預計在分析期內，尿液分析部分的複合年成長率為 7.3%。

美國市場規模估計為 5.561 億美元，中國市場預計複合年成長率為 13.4%

預計 2024 年美國妊娠毒血症診斷市場價值將達到 5.561 億美元。作為世界第二大經濟體，中國預計到 2030 年市場規模將達到 7.274 億美元，2024 年至 2030 年的複合年成長率為 13.4%。其他值得注意的區域市場包括日本和加拿大，預計在分析期間的複合年成長率分別為 6.7% 和 8.6%。在歐洲，德國的複合年成長率預計為 7.6%。

全球「妊娠毒血症診斷」市場—主要趨勢與促進因素摘要

為什麼早期發現妊娠毒血症是臨床的首要任務？

併發症症是一種以高血壓和潛在器官損害為特徵的妊娠妊娠毒血症，是全球孕產婦和新生兒發病的主要原因。早期發現非常重要，因為如果不治療妊娠毒血症，它可能會發展成危及生命的子癇或導致早產。隨著醫療保健系統更加重視預防性產前護理，妊娠毒血症的診斷解決方案越來越受到關注。最近的創新包括基於生物標記的血液測試，例如 sFlt-1/PlGF 比率，它可以實現早期和可靠的風險分層。攜帶式分析儀和數位監控的就地檢驗也正在興起，為都市區醫院和偏遠診所的產婦護理提供支援。這些診斷技術可以及時干預，改善懷孕結果，減輕加護治療服務的負擔，從而改變產婦護理。

推動診斷能力發展的相關人員誰？

這個不斷發展的市場的相關人員包括醫療設備製造商、產科護理提供者、學術研究人員和公共衛生組織。診斷公司正在開發靈敏度和特異性不斷提高的檢測方法，以便在臨床症狀出現之前就檢測出血清或血漿中的生物標記。醫院和產前診斷診所正在將這些測試納入標準護理途徑，以便儘早對高風險懷孕進行分層。同時，研究實驗室正在調查可用於下一代診斷的基因組和蛋白質組特徵。世界衛生組織和聯合國兒童基金會等全球衛生組織正在推廣孕產婦篩檢計劃，特別是在妊娠毒血症相關死亡率仍然很高的低收入國家。公共和私營部門正在透過補貼計劃和行動醫療舉措合作擴大獲得可負擔診斷服務的機會。

全球市場如何跨地區適應？

各地區對妊娠毒血症診斷的採用情況因醫療保健基礎設施、孕產婦死亡率和監管準備而異。由於建立了篩檢通訊協定，並且擁有支持高級測試的廣泛保險覆蓋範圍，北美和西歐是領先的收養國家。在亞太地區，由於人們認知的提高和產婦保健基礎設施的擴大，中國、日本和印度的都市區正在迅速採用生物標記檢測。撒哈拉以南非洲和拉丁美洲的部分地區面臨醫療服務可近性和可負擔性的挑戰，但行動診所和遠端醫療平台正在填補一些空白。在已開發市場的捐贈和技術轉移的支持下，全球舉措正在促進照護現場診斷工具在這些醫療服務欠缺地區的廣泛部署。這些地區的差異反映了孕產婦保健優先事項的成熟度和緊迫性的不同程度。

是什麼推動了診斷解決方案的擴展？

妊娠毒血症診斷市場的成長受到臨床需求、醫療保健政策和技術進步等多種因素的推動。隨著人們對孕產婦健康風險和早期療育益處的認知不斷提高，婦產科醫生正在將基於生物標記的檢測作為常規產前護理的一部分。免疫測量、生物感測器和微流體的發展促進了快速、準確和可擴展的診斷平台的開發。由於孕婦年齡成長、肥胖、高血壓病史等因素導致高風險懷孕的增加，增加了可靠篩檢的需求。已開發國家和新興國家均推出了支持性衛生政策和產前護理獎勵，以促進市場發展。此外，診斷開發商和醫療保健非政府組織之間的夥伴關係使得在資源有限的環境中能夠以經濟高效的方式部署測試解決方案，從而擴大全球影響力。

部分

檢驗類型（血液檢測、尿液分析、其他檢驗類型）；產品類型（儀器、耗材）；最終使用者（醫院、專科診所、診斷中心、其他最終使用者）

受訪公司範例（43家值得關注的公司）

• Abbott Laboratories
• ACON Laboratories, Inc.
• Agilent Technologies, Inc.
• Bayer AG
• Beckman Coulter, Inc.
• Becton, Dickinson and Company
• bioMerieux SA
• Bio-Rad Laboratories, Inc.
• Diabetomics, Inc.
• DRG Instruments GmbH
• F. Hoffmann-La Roche Ltd
• Illumina, Inc.
• Metabolomic Diagnostics Ltd.
• Natera, Inc.
• PerkinElmer Inc.
• QuidelOrtho Corporation
• Sera Prognostics, Inc.
• Siemens Healthineers AG
• Thermo Fisher Scientific Inc.
• Trinity Biotech plc

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地以及進出口（成品和OEM）預測公司競爭地位的變化。這種複雜且多方面的市場動態預計將以多種方式影響競爭對手，包括人為提高銷貨成本、降低盈利、重組供應鏈等微觀和宏觀市場動態。

全球產業分析師密切關注世界領先的首席經濟學家（14,949）、智庫（62）和貿易及產業協會（171）的專家意見，以評估生態系統的影響並應對新的市場現實。各主要國家的專家和經濟學家都在關注關稅及其對國家的影響。

全球產業分析師預計，這種動盪將在未來幾個月內平息，新的世界秩序將更加明確地建立。全球產業分析師正在即時追蹤這些發展。

2025年4月：談判階段

我們四月份的發布將涵蓋關稅對全球市場整體的影響，並為各地區的市場調整提供指導。我們的預測是基於歷史數據和不斷發展的市場影響因素。

2025年7月：最終關稅調整

在各國宣布最終重置後，客戶也將於 7 月收到免費更新。最終更新包含明確的關稅影響分析。

相互和雙邊貿易及關稅影響分析：

美國<>中國<>墨西哥<>加拿大<>歐盟<>日本<>印度<>其他176個國家

領先的產業經濟學家：全球產業分析師知識庫追蹤 14,949 位經濟學家，其中包括來自民族國家、智庫、貿易和產業協會、大型企業和領域專家的最具影響力的首席經濟學家，他們共用了全球經濟狀況這一前所未有的模式轉移的影響。我們的 16,491 多份報告中的大多數都遵循這個基於兩階段里程碑的發布計劃。

目錄

第1章調查方法

第2章執行摘要

• 市場概覽
• 主要企業
• 市場趨勢和促進因素
• 全球市場展望

第3章市場分析

• 美國
• 加拿大
• 日本
• 中國
• 歐洲
• 法國
• 德國
• 義大利
• 英國
• 西班牙
• 俄羅斯
• 其他歐洲國家
• 亞太地區
• 澳洲
• 印度
• 韓國
• 其他亞太地區
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中東
• 伊朗
• 以色列
• 沙烏地阿拉伯
• 阿拉伯聯合大公國
• 其他中東地區
• 非洲

第4章 競賽

Global Preeclampsia Diagnostics Market to Reach US$3.5 Billion by 2030

The global market for Preeclampsia Diagnostics estimated at US$2.0 Billion in the year 2024, is expected to reach US$3.5 Billion by 2030, growing at a CAGR of 9.6% over the analysis period 2024-2030. Blood Tests, one of the segments analyzed in the report, is expected to record a 11.0% CAGR and reach US$2.2 Billion by the end of the analysis period. Growth in the Urine Analysis segment is estimated at 7.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$556.1 Million While China is Forecast to Grow at 13.4% CAGR

The Preeclampsia Diagnostics market in the U.S. is estimated at US$556.1 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$727.4 Million by the year 2030 trailing a CAGR of 13.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.7% and 8.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.6% CAGR.

Global "Preeclampsia Diagnostics" Market - Key Trends & Drivers Summarized

Why Is Early Detection of Preeclampsia Gaining Clinical Priority?

Preeclampsia, a pregnancy complication marked by high blood pressure and potential organ damage, is a leading cause of maternal and neonatal morbidity worldwide. Early detection is critical, as untreated preeclampsia can escalate into life-threatening eclampsia or lead to premature births. As healthcare systems emphasize preventive prenatal care, diagnostic solutions for preeclampsia are receiving increased attention. Recent innovations include biomarker-based blood tests such as the sFlt-1/PlGF ratio, which enables early and reliable risk stratification. Point-of-care testing, integrated with portable analyzers and digital monitoring, is also emerging to support maternal care in both urban hospitals and remote clinics. These diagnostics are reshaping prenatal care by enabling timely intervention, thereby improving pregnancy outcomes and reducing the burden on intensive care services.

Who Are the Primary Stakeholders Advancing Diagnostic Capabilities?

Stakeholders in this evolving market include medical device manufacturers, obstetric care providers, academic researchers, and public health agencies. Diagnostic companies are developing assays with higher sensitivity and specificity to detect biomarkers in serum or plasma well before clinical symptoms appear. Hospitals and prenatal clinics are integrating these tests into standard care pathways to stratify high-risk pregnancies early on. Meanwhile, research institutions are exploring genomic and proteomic signatures for potential use in next-gen diagnostics. Global health agencies such as WHO and UNICEF are promoting maternal screening programs, particularly in low-income countries where preeclampsia-related mortality remains high. Collaborations between public entities and private players are expanding access to affordable diagnostics through subsidized programs and mobile health initiatives.

How Is the Global Market Adapting Across Regions?

Regional adoption of preeclampsia diagnostics varies based on healthcare infrastructure, maternal mortality rates, and regulatory readiness. North America and Western Europe are leading adopters, with established screening protocols and widespread insurance coverage supporting advanced testing. In Asia-Pacific, urban areas in China, Japan, and India are seeing rapid implementation of biomarker assays, driven by rising awareness and the expansion of maternal care infrastructure. Sub-Saharan Africa and parts of Latin America face challenges with access and affordability, but mobile clinics and telehealth platforms are bridging some gaps. Global initiatives are encouraging broader deployment of point-of-care diagnostic tools in these underserved regions, supported by donations and technology transfer from developed markets. These regional variations reflect the diverse maturity levels and urgency surrounding maternal health priorities.

What Is Driving the Expansion of Diagnostic Solutions?

The growth in the preeclampsia diagnostics market is driven by several factors rooted in clinical demand, healthcare policy, and technological evolution. Rising awareness of maternal health risks and early intervention benefits is pushing obstetricians and gynecologists to adopt biomarker-based tests as part of routine prenatal care. Advances in immunoassays, biosensors, and microfluidics have enabled the development of fast, accurate, and scalable diagnostic platforms. The increasing prevalence of high-risk pregnancies-due to factors such as older maternal age, obesity, and pre-existing hypertension-is amplifying the need for reliable screening. Supportive health policies and prenatal care incentives in both developed and developing countries are facilitating wider market access. Furthermore, partnerships between diagnostic developers and healthcare NGOs are enabling cost-effective deployment of testing solutions in resource-limited settings, thereby enhancing global penetration and impact.

SCOPE OF STUDY:

The report analyzes the Preeclampsia Diagnostics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Test Type (Blood Tests, Urine Analysis, Other Test Types); Product Type (Instruments, Consumables); End-User (Hospitals, Specialty Clinics, Diagnostic Centers, Other End-Users)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 43 Featured) -

• Abbott Laboratories
• ACON Laboratories, Inc.
• Agilent Technologies, Inc.
• Bayer AG
• Beckman Coulter, Inc.
• Becton, Dickinson and Company
• bioMerieux SA
• Bio-Rad Laboratories, Inc.
• Diabetomics, Inc.
• DRG Instruments GmbH
• F. Hoffmann-La Roche Ltd
• Illumina, Inc.
• Metabolomic Diagnostics Ltd.
• Natera, Inc.
• PerkinElmer Inc.
• QuidelOrtho Corporation
• Sera Prognostics, Inc.
• Siemens Healthineers AG
• Thermo Fisher Scientific Inc.
• Trinity Biotech plc

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession
  • Preeclampsia Diagnostics - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rise in Maternal Mortality Awareness Throws Spotlight on Early Preeclampsia Diagnostics
  • Advancements in Biomarker-Based Testing Propel Accuracy in Risk Stratification
  • Government-Backed Maternal Health Programs Drive Diagnostic Testing Accessibility
  • Growing Prenatal Screening Adoption Expands Addressable Market for Preeclampsia Tests
  • Integration of AI and Predictive Models Enhances Diagnostic Decision Support Systems
  • First-Trimester Risk Screening Gains Traction for Early Prevention and Monitoring
  • Shift Toward Point-of-Care Diagnostics Strengthens Case for Portable Preeclampsia Test Kits
  • Increased Investment in Womens Health Innovation Spurs R&D in Novel Testing Methods
  • Healthcare Equity Initiatives Drive Focus on Underserved Populations in LMICs
  • Rising Use of Telehealth Platforms Expands Reach of Remote Diagnostic Consultations
  • Incorporation of Multi-Omics and Genetic Markers Enhances Predictive Testing Accuracy
  • Growing Awareness Among OB/GYNs and Midwives Accelerates Screening Rates
  • Private-Public Collaborations Support Development of Cost-Effective Diagnostic Tools
  • Postpartum Monitoring Programs Propel Demand for Repeat or Follow-Up Diagnostic Use
  • Clinical Guidelines and Protocol Updates Encourage Routine Screening in High-Risk Populations
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Preeclampsia Diagnostics Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Preeclampsia Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Preeclampsia Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Blood Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Blood Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Blood Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Urine Analysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Urine Analysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Urine Analysis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Other Test Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Other Test Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Other Test Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Specialty Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Specialty Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Specialty Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Other End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Preeclampsia Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 32: USA Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 33: USA Historic Review for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: USA 15-Year Perspective for Preeclampsia Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood Tests, Urine Analysis and Other Test Types for the Years 2015, 2025 & 2030
  • TABLE 35: USA Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Product Type - Instruments and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 36: USA Historic Review for Preeclampsia Diagnostics by Product Type - Instruments and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: USA 15-Year Perspective for Preeclampsia Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables for the Years 2015, 2025 & 2030
  • TABLE 38: USA Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 39: USA Historic Review for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: USA 15-Year Perspective for Preeclampsia Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 41: Canada Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 42: Canada Historic Review for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: Canada 15-Year Perspective for Preeclampsia Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood Tests, Urine Analysis and Other Test Types for the Years 2015, 2025 & 2030
  • TABLE 44: Canada Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Product Type - Instruments and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: Canada Historic Review for Preeclampsia Diagnostics by Product Type - Instruments and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: Canada 15-Year Perspective for Preeclampsia Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables for the Years 2015, 2025 & 2030
  • TABLE 47: Canada Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Canada Historic Review for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: Canada 15-Year Perspective for Preeclampsia Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users for the Years 2015, 2025 & 2030
• JAPAN
  • Preeclampsia Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 50: Japan Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Japan Historic Review for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: Japan 15-Year Perspective for Preeclampsia Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood Tests, Urine Analysis and Other Test Types for the Years 2015, 2025 & 2030
  • TABLE 53: Japan Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Product Type - Instruments and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Japan Historic Review for Preeclampsia Diagnostics by Product Type - Instruments and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: Japan 15-Year Perspective for Preeclampsia Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables for the Years 2015, 2025 & 2030
  • TABLE 56: Japan Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Japan Historic Review for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: Japan 15-Year Perspective for Preeclampsia Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users for the Years 2015, 2025 & 2030
• CHINA
  • Preeclampsia Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 59: China Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: China Historic Review for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: China 15-Year Perspective for Preeclampsia Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood Tests, Urine Analysis and Other Test Types for the Years 2015, 2025 & 2030
  • TABLE 62: China Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Product Type - Instruments and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: China Historic Review for Preeclampsia Diagnostics by Product Type - Instruments and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: China 15-Year Perspective for Preeclampsia Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables for the Years 2015, 2025 & 2030
  • TABLE 65: China Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: China Historic Review for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: China 15-Year Perspective for Preeclampsia Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users for the Years 2015, 2025 & 2030
• EUROPE
  • Preeclampsia Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 68: Europe Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 69: Europe Historic Review for Preeclampsia Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: Europe 15-Year Perspective for Preeclampsia Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 71: Europe Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Europe Historic Review for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: Europe 15-Year Perspective for Preeclampsia Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood Tests, Urine Analysis and Other Test Types for the Years 2015, 2025 & 2030
  • TABLE 74: Europe Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Product Type - Instruments and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Europe Historic Review for Preeclampsia Diagnostics by Product Type - Instruments and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: Europe 15-Year Perspective for Preeclampsia Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables for the Years 2015, 2025 & 2030
  • TABLE 77: Europe Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: Europe 15-Year Perspective for Preeclampsia Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users for the Years 2015, 2025 & 2030
• FRANCE
  • Preeclampsia Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 80: France Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: France Historic Review for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: France 15-Year Perspective for Preeclampsia Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood Tests, Urine Analysis and Other Test Types for the Years 2015, 2025 & 2030
  • TABLE 83: France Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Product Type - Instruments and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: France Historic Review for Preeclampsia Diagnostics by Product Type - Instruments and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: France 15-Year Perspective for Preeclampsia Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables for the Years 2015, 2025 & 2030
  • TABLE 86: France Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: France Historic Review for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: France 15-Year Perspective for Preeclampsia Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users for the Years 2015, 2025 & 2030
• GERMANY
  • Preeclampsia Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 89: Germany Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Germany Historic Review for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: Germany 15-Year Perspective for Preeclampsia Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood Tests, Urine Analysis and Other Test Types for the Years 2015, 2025 & 2030
  • TABLE 92: Germany Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Product Type - Instruments and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Germany Historic Review for Preeclampsia Diagnostics by Product Type - Instruments and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: Germany 15-Year Perspective for Preeclampsia Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables for the Years 2015, 2025 & 2030
  • TABLE 95: Germany Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Germany Historic Review for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: Germany 15-Year Perspective for Preeclampsia Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 98: Italy Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Italy Historic Review for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: Italy 15-Year Perspective for Preeclampsia Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood Tests, Urine Analysis and Other Test Types for the Years 2015, 2025 & 2030
  • TABLE 101: Italy Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Product Type - Instruments and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Italy Historic Review for Preeclampsia Diagnostics by Product Type - Instruments and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: Italy 15-Year Perspective for Preeclampsia Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables for the Years 2015, 2025 & 2030
  • TABLE 104: Italy Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Italy Historic Review for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: Italy 15-Year Perspective for Preeclampsia Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Preeclampsia Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 107: UK Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: UK Historic Review for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: UK 15-Year Perspective for Preeclampsia Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood Tests, Urine Analysis and Other Test Types for the Years 2015, 2025 & 2030
  • TABLE 110: UK Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Product Type - Instruments and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: UK Historic Review for Preeclampsia Diagnostics by Product Type - Instruments and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: UK 15-Year Perspective for Preeclampsia Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables for the Years 2015, 2025 & 2030
  • TABLE 113: UK Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: UK Historic Review for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: UK 15-Year Perspective for Preeclampsia Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 116: Spain Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Spain Historic Review for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: Spain 15-Year Perspective for Preeclampsia Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood Tests, Urine Analysis and Other Test Types for the Years 2015, 2025 & 2030
  • TABLE 119: Spain Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Product Type - Instruments and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Spain Historic Review for Preeclampsia Diagnostics by Product Type - Instruments and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: Spain 15-Year Perspective for Preeclampsia Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables for the Years 2015, 2025 & 2030
  • TABLE 122: Spain Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Spain Historic Review for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: Spain 15-Year Perspective for Preeclampsia Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 125: Russia Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Russia Historic Review for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: Russia 15-Year Perspective for Preeclampsia Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood Tests, Urine Analysis and Other Test Types for the Years 2015, 2025 & 2030
  • TABLE 128: Russia Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Product Type - Instruments and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Russia Historic Review for Preeclampsia Diagnostics by Product Type - Instruments and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: Russia 15-Year Perspective for Preeclampsia Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables for the Years 2015, 2025 & 2030
  • TABLE 131: Russia Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Russia Historic Review for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Russia 15-Year Perspective for Preeclampsia Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Rest of Europe Historic Review for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: Rest of Europe 15-Year Perspective for Preeclampsia Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood Tests, Urine Analysis and Other Test Types for the Years 2015, 2025 & 2030
  • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Product Type - Instruments and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Rest of Europe Historic Review for Preeclampsia Diagnostics by Product Type - Instruments and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: Rest of Europe 15-Year Perspective for Preeclampsia Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables for the Years 2015, 2025 & 2030
  • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Rest of Europe Historic Review for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: Rest of Europe 15-Year Perspective for Preeclampsia Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Preeclampsia Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 144: Asia-Pacific Historic Review for Preeclampsia Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: Asia-Pacific 15-Year Perspective for Preeclampsia Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Asia-Pacific Historic Review for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: Asia-Pacific 15-Year Perspective for Preeclampsia Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood Tests, Urine Analysis and Other Test Types for the Years 2015, 2025 & 2030
  • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Product Type - Instruments and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Asia-Pacific Historic Review for Preeclampsia Diagnostics by Product Type - Instruments and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: Asia-Pacific 15-Year Perspective for Preeclampsia Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables for the Years 2015, 2025 & 2030
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Asia-Pacific 15-Year Perspective for Preeclampsia Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Preeclampsia Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 155: Australia Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Australia Historic Review for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Australia 15-Year Perspective for Preeclampsia Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood Tests, Urine Analysis and Other Test Types for the Years 2015, 2025 & 2030
  • TABLE 158: Australia Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Product Type - Instruments and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Australia Historic Review for Preeclampsia Diagnostics by Product Type - Instruments and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Australia 15-Year Perspective for Preeclampsia Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables for the Years 2015, 2025 & 2030
  • TABLE 161: Australia Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Australia Historic Review for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: Australia 15-Year Perspective for Preeclampsia Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users for the Years 2015, 2025 & 2030
• INDIA
  • Preeclampsia Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 164: India Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: India Historic Review for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: India 15-Year Perspective for Preeclampsia Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood Tests, Urine Analysis and Other Test Types for the Years 2015, 2025 & 2030
  • TABLE 167: India Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Product Type - Instruments and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: India Historic Review for Preeclampsia Diagnostics by Product Type - Instruments and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: India 15-Year Perspective for Preeclampsia Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables for the Years 2015, 2025 & 2030
  • TABLE 170: India Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: India Historic Review for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: India 15-Year Perspective for Preeclampsia Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 173: South Korea Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: South Korea Historic Review for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: South Korea 15-Year Perspective for Preeclampsia Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood Tests, Urine Analysis and Other Test Types for the Years 2015, 2025 & 2030
  • TABLE 176: South Korea Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Product Type - Instruments and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: South Korea Historic Review for Preeclampsia Diagnostics by Product Type - Instruments and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: South Korea 15-Year Perspective for Preeclampsia Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables for the Years 2015, 2025 & 2030
  • TABLE 179: South Korea Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: South Korea Historic Review for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: South Korea 15-Year Perspective for Preeclampsia Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Rest of Asia-Pacific Historic Review for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: Rest of Asia-Pacific 15-Year Perspective for Preeclampsia Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood Tests, Urine Analysis and Other Test Types for the Years 2015, 2025 & 2030
  • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Product Type - Instruments and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Rest of Asia-Pacific Historic Review for Preeclampsia Diagnostics by Product Type - Instruments and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Preeclampsia Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables for the Years 2015, 2025 & 2030
  • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Rest of Asia-Pacific Historic Review for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Preeclampsia Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Preeclampsia Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 191: Latin America Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 192: Latin America Historic Review for Preeclampsia Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: Latin America 15-Year Perspective for Preeclampsia Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 194: Latin America Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Latin America Historic Review for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: Latin America 15-Year Perspective for Preeclampsia Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood Tests, Urine Analysis and Other Test Types for the Years 2015, 2025 & 2030
  • TABLE 197: Latin America Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Product Type - Instruments and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Latin America Historic Review for Preeclampsia Diagnostics by Product Type - Instruments and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Latin America 15-Year Perspective for Preeclampsia Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables for the Years 2015, 2025 & 2030
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Latin America 15-Year Perspective for Preeclampsia Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 203: Argentina Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Argentina Historic Review for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Argentina 15-Year Perspective for Preeclampsia Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood Tests, Urine Analysis and Other Test Types for the Years 2015, 2025 & 2030
  • TABLE 206: Argentina Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Product Type - Instruments and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Argentina Historic Review for Preeclampsia Diagnostics by Product Type - Instruments and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Argentina 15-Year Perspective for Preeclampsia Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables for the Years 2015, 2025 & 2030
  • TABLE 209: Argentina Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Argentina Historic Review for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Argentina 15-Year Perspective for Preeclampsia Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 212: Brazil Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Brazil Historic Review for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: Brazil 15-Year Perspective for Preeclampsia Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood Tests, Urine Analysis and Other Test Types for the Years 2015, 2025 & 2030
  • TABLE 215: Brazil Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Product Type - Instruments and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Brazil Historic Review for Preeclampsia Diagnostics by Product Type - Instruments and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: Brazil 15-Year Perspective for Preeclampsia Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables for the Years 2015, 2025 & 2030
  • TABLE 218: Brazil Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Brazil Historic Review for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: Brazil 15-Year Perspective for Preeclampsia Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 221: Mexico Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Mexico Historic Review for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: Mexico 15-Year Perspective for Preeclampsia Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood Tests, Urine Analysis and Other Test Types for the Years 2015, 2025 & 2030
  • TABLE 224: Mexico Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Product Type - Instruments and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Mexico Historic Review for Preeclampsia Diagnostics by Product Type - Instruments and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: Mexico 15-Year Perspective for Preeclampsia Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables for the Years 2015, 2025 & 2030
  • TABLE 227: Mexico Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Mexico Historic Review for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: Mexico 15-Year Perspective for Preeclampsia Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Rest of Latin America Historic Review for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: Rest of Latin America 15-Year Perspective for Preeclampsia Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood Tests, Urine Analysis and Other Test Types for the Years 2015, 2025 & 2030
  • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Product Type - Instruments and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Rest of Latin America Historic Review for Preeclampsia Diagnostics by Product Type - Instruments and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: Rest of Latin America 15-Year Perspective for Preeclampsia Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables for the Years 2015, 2025 & 2030
  • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Rest of Latin America Historic Review for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: Rest of Latin America 15-Year Perspective for Preeclampsia Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Preeclampsia Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 239: Middle East Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 240: Middle East Historic Review for Preeclampsia Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: Middle East 15-Year Perspective for Preeclampsia Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 242: Middle East Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Middle East Historic Review for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: Middle East 15-Year Perspective for Preeclampsia Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood Tests, Urine Analysis and Other Test Types for the Years 2015, 2025 & 2030
  • TABLE 245: Middle East Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Product Type - Instruments and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Middle East Historic Review for Preeclampsia Diagnostics by Product Type - Instruments and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: Middle East 15-Year Perspective for Preeclampsia Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables for the Years 2015, 2025 & 2030
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Middle East 15-Year Perspective for Preeclampsia Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 251: Iran Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Iran Historic Review for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Iran 15-Year Perspective for Preeclampsia Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood Tests, Urine Analysis and Other Test Types for the Years 2015, 2025 & 2030
  • TABLE 254: Iran Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Product Type - Instruments and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Iran Historic Review for Preeclampsia Diagnostics by Product Type - Instruments and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Iran 15-Year Perspective for Preeclampsia Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables for the Years 2015, 2025 & 2030
  • TABLE 257: Iran Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Iran Historic Review for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Iran 15-Year Perspective for Preeclampsia Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 260: Israel Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Israel Historic Review for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Israel 15-Year Perspective for Preeclampsia Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood Tests, Urine Analysis and Other Test Types for the Years 2015, 2025 & 2030
  • TABLE 263: Israel Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Product Type - Instruments and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Israel Historic Review for Preeclampsia Diagnostics by Product Type - Instruments and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Israel 15-Year Perspective for Preeclampsia Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables for the Years 2015, 2025 & 2030
  • TABLE 266: Israel Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Israel Historic Review for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Israel 15-Year Perspective for Preeclampsia Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Saudi Arabia Historic Review for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Saudi Arabia 15-Year Perspective for Preeclampsia Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood Tests, Urine Analysis and Other Test Types for the Years 2015, 2025 & 2030
  • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Product Type - Instruments and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Saudi Arabia Historic Review for Preeclampsia Diagnostics by Product Type - Instruments and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Saudi Arabia 15-Year Perspective for Preeclampsia Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables for the Years 2015, 2025 & 2030
  • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Saudi Arabia Historic Review for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: Saudi Arabia 15-Year Perspective for Preeclampsia Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 278: UAE Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: UAE Historic Review for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: UAE 15-Year Perspective for Preeclampsia Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood Tests, Urine Analysis and Other Test Types for the Years 2015, 2025 & 2030
  • TABLE 281: UAE Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Product Type - Instruments and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: UAE Historic Review for Preeclampsia Diagnostics by Product Type - Instruments and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: UAE 15-Year Perspective for Preeclampsia Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables for the Years 2015, 2025 & 2030
  • TABLE 284: UAE Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: UAE Historic Review for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: UAE 15-Year Perspective for Preeclampsia Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Rest of Middle East Historic Review for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: Rest of Middle East 15-Year Perspective for Preeclampsia Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood Tests, Urine Analysis and Other Test Types for the Years 2015, 2025 & 2030
  • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Product Type - Instruments and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Rest of Middle East Historic Review for Preeclampsia Diagnostics by Product Type - Instruments and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: Rest of Middle East 15-Year Perspective for Preeclampsia Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables for the Years 2015, 2025 & 2030
  • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Rest of Middle East Historic Review for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: Rest of Middle East 15-Year Perspective for Preeclampsia Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users for the Years 2015, 2025 & 2030
• AFRICA
  • Preeclampsia Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 296: Africa Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Africa Historic Review for Preeclampsia Diagnostics by Test Type - Blood Tests, Urine Analysis and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: Africa 15-Year Perspective for Preeclampsia Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood Tests, Urine Analysis and Other Test Types for the Years 2015, 2025 & 2030
  • TABLE 299: Africa Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by Product Type - Instruments and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Africa Historic Review for Preeclampsia Diagnostics by Product Type - Instruments and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: Africa 15-Year Perspective for Preeclampsia Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables for the Years 2015, 2025 & 2030
  • TABLE 302: Africa Recent Past, Current & Future Analysis for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Africa Historic Review for Preeclampsia Diagnostics by End-user - Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: Africa 15-Year Perspective for Preeclampsia Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers and Other End-Users for the Years 2015, 2025 & 2030

IV. COMPETITION